RecruitingNCT06356467
Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs
Studying Gastroenteropancreatic neuroendocrine neoplasm
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IRCCS San Raffaele
- Principal Investigator
- Gabriele Capurso, PhDIRCCS Ospedale San Raffaele
- Enrollment
- 450 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- IRCCS OSpedale San Raffaele, Milan, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06356467 on ClinicalTrials.govOther trials for Gastroenteropancreatic neuroendocrine neoplasm
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1NCT05262556NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine CarcinomasAmr Mohamed MD
- ACTIVE NOT RECRUITINGPHASE1NCT04750954Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine TumorsNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNANCT03012789Surgical Intervention and the NETestWren Laboratories LLC
See all trials for Gastroenteropancreatic neuroendocrine neoplasm →